13F HOLDINGS REPORT
Fairmount Funds Management LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001104659-24-061870
Total Value
$917.4M
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AXSOME THERAPEUTICS INC | AXSM | 2,360,077 | $188.3M | 20.53% |
| 2 | NUVALENT INC | NUVL | 1,924,626 | $144.5M | 15.75% |
| 3 | APOGEE THERAPEUTICS INC | APGE | 2,048,647 | $136.1M | 14.84% |
| 4 | DIANTHUS THERAPEUTICS INC | DNTH | 2,762,837 | $82.9M | 9.03% |
| 5 | KINIKSA PHARMACEUTICALS LTD | KNSA | 3,204,841 | $63.2M | 6.89% |
| 6 | ENLIVEN THERAPEUTICS INC | ELVN | 3,202,798 | $56.3M | 6.14% |
| 7 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,554,129 | $50.0M | 5.45% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 1,845,813 | $32.3M | 3.52% |
| 9 | MERUS N V | N5749R100 | 717,254 | $32.3M | 3.52% |
| 10 | COGENT BIOSCIENCES INC | COGT | 4,725,641 | $31.8M | 3.46% |
| 11 | PROTAGONIST THERAPEUTICS INC | PTGX | 931,890 | $27.0M | 2.94% |
| 12 | TYRA BIOSCIENCES INC | TYRA | 1,393,329 | $22.9M | 2.49% |
| 13 | GERON CORP | GERN | 6,666,667 | $22.0M | 2.40% |
| 14 | SPYRE THERAPEUTICS INC | SYRE | 378,421 | $14.4M | 1.56% |
| 15 | TERNS PHARMACEUTICALS INC | TERN | 2,040,000 | $13.4M | 1.46% |